middle east respiratory syndrome coronavirus (mers-cov): hajj issue for iran
Authors
abstract
every year, millions of muslims from all over the world, are going to participate in the pilgrimage hajj located in mecca in kingdom of saudi arabia (ksa). the accumulation of many people from all parts of the world in terms of health management is of great importance. in fact, every person could be a carrier of various chronic or acute diseases. this huge population may lead to occurrence of several epidemics, especially respiratory infections. iran, as one of the biggest muslem countries in the middle east will annually send many people to mecca. in 2015, more than 65 thousands of iranian pilgrims hajj went to the mecca. . the management of disease is mainly for the symptoms; for example, patients with breathing difficulties would be supported with a machine to provide extra oxygen, or be given medication for fever. there is no vaccine yet; and in the best-case scenario, it would take at least three years to develop one.
similar resources
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Hajj issue for Iran
Every year, millions of Muslims from all over the world, are going to participate in the pilgrimage Hajj, located in Mecca in Saudi Arabia. There are two types of Hajj: Great Hajj and Umrah Hajj. Great pilgrimage or Hajj is obligatory for each Muslim once in entire his/her life and will occur only once a year; i.e. in the 11th month of Arabic calendar. Due to the nature of Arabic calendar...
full textMiddle East Respiratory Syndrome Coronavirus (MERS-CoV): A Review Article
The recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in the Middle East region in 2012. The virus is phylogenetically related to bat CoV, but other animal species like camels and goats may potentially act as an intermediate host by spreading the virus to humans. This virus is thought to cause a severe disease in patients with underlying comorbidities. Laboratory ...
full textUpdate: Recommendations for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
On June 11, 2013, CDC issued interim infection prevention and control recommendations for hospitalized patients with known or suspected Middle East respiratory syndrome coronavirus (MERS-CoV) infection in U.S. hospitals. To date, no MERS-CoV cases have been reported in the United States; however, cases have been reported in eight other countries. Recent published reports have described limited ...
full textUpdate on Middle East respiratory syndrome coronavirus (MERS-CoV).
Background: Since April 2012, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been confirmed in 8 countries: France, Italy, Jordan, Qatar, Saudi Arabia, Tunisia, United Kingdom (UK) and United Arab Emirates (UAE). Of 55 laboratory-confirmed cases, 31 were fatal for a case fatality rate of 56% (current CDC data June 7, 2013). Although no cases have been reported in the US as of June ...
full textMiddle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013.
Middle East Respiratory Syndrome coronavirus (MERS CoV) came to attention as an emerging pathogen causing severe respiratory illness in patients from the Middle East in September 2012. As of 14 June 2013, 58 human cases of MERS CoV infection have been confirmed, including 33 deaths (case fatality rate of 57%). MERS CoV is a beta-coronavirus, in the same family as SARS-CoV, and shares a probable...
full textMy Resources
Save resource for easier access later
Journal title:
international journal of epidemiologic researchPublisher: shahrekord university of medical sciences
ISSN
volume 2
issue 3 2015
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023